Vigabatrin. GVG, MDL 71754, RMI 71754, Sabril, Sabrilex, gamma-vinyl-GABA.
D000328:Adult; D002986:Clinical Trials as Topic; D018492:Dopamine Antagonists / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004311:Double-Blind Method; D004347:Drug Interactions; D006207:Half-Life; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D020888:Vigabatrin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D018492:Dopamine Antagonists; D010919:Placebos; D020888:Vigabatrin